Study Tests Two Targeted Therapies Against Advanced Breast Cancer.

AScribe Health News Service, June, 2003

Byline: UCLA

LOS ANGELES, June 16 (AScribe Newswire) -- A new, early phase study at UCLA's Jonsson Cancer Center for the first time pairs two molecularly targeted drugs as a one-two punch to fight metastatic breast cancer. The drugs attack only the cancer and the blood vessel cells, and leave the healthy cells unharmed.

Jonsson Cancer Center researchers are seeking volunteers with untreated, HER-2/neu positive advanced breast cancer to participate in the research, which does not use chemotherapy or other conventional treatments. The study combines the monoclonal antibody Herceptin with the experimental angiogenesis inhibitor Avastin, which current studies indicate may extend the lives of patients with advanced colorectal cancer.

"Other...

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement